SUBSCRIBE
SUBSCRIBE

Vertex Pharmaceuticals

NEWS
Deals
4 Possible Biotech Takeover Targets for 2018
This year wasn’t big for mergers and acquisitions in biopharma, particularly compared to 2015 and 2016.
December 12, 2017
 · 
3 min read
 · 
Mark Terry
Genetown
The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More
Keith Speights, writing for The Motley Fool, notes one biotech that’s booming.
November 22, 2017
 · 
3 min read
 · 
Mark Terry
Gemini Therapeutics Banks $42.5M to Bring Precisio
Biotech Bay
Top 5 Best Biotechs That Could Beat Estimates in Q3
The Q3 earnings season is approaching its end with 81.2% of the S&P 500 companies having already released results.
November 8, 2017
 · 
1 min read
Gemini Therapeutics Banks $42.5M to Bring Precisio
Pharm Country
This Massachusetts Pharma Doubled Its Market Cap in 2017, What’s Next?
Vertex has done everything an investor could ask for in 2017, including double its market cap to almost $40B.
October 18, 2017
 · 
1 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Biotech Bay
Why Booming Vertex is on Its Way to Becoming Gilead’s Mini-Me
September 28, 2017
 · 
3 min read
Pharm Country
2 Views On Vertex Stock: Short Term Vs. Long Term
September 12, 2017
 · 
1 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Drug Development
Vertex’s Terminated Phase II CF Trial Was Planned
September 12, 2017
 · 
2 min read
Pharm Country
Vertex May Be Turning Some Major Corners
August 14, 2017
 · 
1 min read
Pharm Country
For Vertex, Can One Billion-Dollar Breakthrough Beget Another?
August 9, 2017
 · 
1 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Vertex Announces Planned Initiation Of Phase 2 Studies Evaluating The Next-Generation Correctors VX-440 And VX-152 In Triple Combination Regimens To Treat The Underlying Cause Of Cystic Fibrosis
October 26, 2016
 · 
15 min read
Business
Vertex Reports Third Quarter 2016 Financial Results
October 26, 2016
 · 
1 min read
Drug Development
Vertex to Test Next-Generation CF Drugs by End of Year
October 26, 2016
 · 
1 min read
Business
Vertex To Announce Third Quarter 2016 Financial Results On October 25
October 7, 2016
 · 
1 min read
FDA
Vertex Release: FDA Approves ORKAMBI (Lumacaftor/Ivacaftor) For Use In Children With Cystic Fibrosis Ages 6 Through 11 Who Have Two Copies Of The F508del Mutation
September 29, 2016
 · 
10 min read
Genetown
Vertex To Present At Upcoming Investor Conferences
September 12, 2016
 · 
1 min read
Business
Ophthotech Corporation Announces Election Of Ian F. Smith, Vertex Executive Vice President And Chief Financial Officer, To Its Board Of Directors
August 2, 2016
 · 
4 min read
Business
Vertex Reports Second Quarter 2016 Financial Results
July 28, 2016
 · 
1 min read
Deals
Trek Therapeutics Acquires Two Antiviral Inhibitors From Vertex
July 26, 2016
 · 
2 min read
Business
Vertex To Announce Second Quarter 2016 Financial Results On July 27
July 14, 2016
 · 
1 min read
Load More